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Abstract
Extramedullary plasmacytoma (EMP) is a plasma cell neoplasm without bone marrow involvement or 
other systemic characteristics of multiple myeloma. Few large-scale clinical studies have been con-
ducted because of the rarity of EMP , especially when it arises from the mediastinum. Herein we report 
a rare case of solitary mediastinal plasmacytoma with reactive pleural effusion. A 58-year-old female 
presented  with  grade  4  dyspnea  and  dysphagia,  with  a  mediastinal  mass  observed  with  on  PET. 
CT-guided biopsy results were suggestive of IgG kappa-type EMP arising from the anterior mediasti-
num. The patient was treated with local radiotherapy to the mediastinum, and had clinical and radio-
logical response s were good. Radiotherapy is an effective treatment for mediastinal EMP , but a com-
plete  workup  is  mandatory,  including  PET,  as  the  majority  of  such  masses  coexist  with  multiple 
myeloma. (Turk J Hematol 2011; 28: 228-31)
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Özet
Ekstramedüller plazmasitom (EMP) kemik iliği tutulumu veya multipl miyelomun diğer sistemik özel-
liklerinin bulunmadığı bir plazma hücre neoplazisidir. Özellikle mediasten kökenli EMP seyrek görül-
düğünden büyük ölçekli klinik çalışma sayısı oldukça azdır. Burada reaktif plevra sıvısı ile birlikte 
mediastende plazmasitomun görüldüğü nadir bir olgu bildirilmektedir. Derece 4 dispne ve disfajiden 
yakınan 58 yaşındaki bir kadında PET incelemesi mediasten kitlesini ortaya çıkarmıştır. CT-yönlendirmeli 
biyopsi bulguları ön mediastenden kaynaklanan IgG kappa-tip EMP tanısını koydurmuştur. Mediastene 
lokal radyoterapi uygulanarak iyi klinik ve radyolojik yanıt elde edilmiştir. Radyoterapi mediasten 
kökenli EMP için etkin bir tedavi olmakla birlikte. bu kitlelerin büyük bir bölümü multipl miyelomla 
birlikte geliştiğinden PET’i de içeren tam bir klinik çalışma yapmak zorunludur. 
(Turk J Hematol 2011; 28: 228-31)
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Extramedullary plasmacytoma (EMP) is a plas-
ma cell neoplasm involving soft tissues without any 
signs of systemic spread. It occurs in <5% of cases 
and mediastinal presentation is. a rare presentation 
Herein we report a rare case of solitary mediastinal 
plasmacytoma and a review of the literature. 
Case presentation
A 58-year-old female presented with upper chest 
swelling associated with grade 4 dyspnea and diffi-
culty swallowing. Physical examination showed a 
4×3-cm supraclavicular mass with diffuse borders 
and a 5×5-cm infraclavicular bulge fixed to underly-
ing structures. Her breathing sounds were slightly 
coarse,  without  rales  or  rhonchi  on  auscultation. 
She was treated in the intensive care unit due to her 
inability  to  maintain  oxygen  saturation.  PET  CT 
showed an anterior mediastinal mass (10.3×8.2 cm) 
extending  up  to  the  left  supraclavicular  region   
(Figure 1). The mass was abutting the major medias-
tinal  vessels,  overlying  the  manubrium  sterni  and 
chest wall, and was associated with bilateral pleural 
effusion.  Cranial,  spinal,  and  pelvic  X-ray  showed 
that there weren’t any osteolytic regions. Light micro-
scopic examination showed scattered oval cells with 
eccentric  nuclei  and  abundant  eosinophilic  cyto-
plasm suggestive of plasmacytoma. The plasma cells 
stained  positive  with  LCA,  CD138,  and  reduced 
kappa  light-chain  concentrations  (Figure  2).  Bone 
marrow biopsy results showed normal patterns of 
cell distribution. Pleural fluid cytological examina-
tion showed lymphocytes and reactive mesothelial 
cells.  Serum  calcium  was  normal  and  urine  was 
negative for Bence Jones proteins. Serum electro-
phoresis showed an M spike in the gamma globulin 
(IgG kappa) region with a value of 3.07 g/dL. Based 
on  these  findings,  the  patient  was  diagnosed  as 
mediastinal  plasmacytoma.  The  patient  received 
3-dimensional conformal external beam radiothera-
py (3D-CRT) to the mediastinum (46.2 Gy in 26 frac-
tions).  Gross  target  volume  GTV  was  contoured 
under  FDG-PET  guidance  with  margins  based  on 
our  institutional  protocol.  The  treatment  was 
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Figure 1. PET/CT shows a 10.3×8.2-cm anterior mediastinal mass 
(SUV: 2.6), with bilateral pleural effusion and collapse of the left 
lung. Saggital (A), coronal (B), and axial (C) views
Figure  2.  Microscopic  examination.  A.  Diffuse  sheets  of  plasma 
cells (H&E, 100×). B. Plasma cells show abundant eosinophilic cy-
toplasm, eccentric cartwheel nuclei with mitosis (thick arrow), and 
para nuclear halos (thin arrow) (H&E, 200×). C and D. Tumor cells 
show kappa light chain restriction (C), but no lambda restriction 
(D) (DAB, 200×)planned  using  a  PLATO  2.7.7  system  and  was 
administered  under  imaging  guidance.  Clinical 
improvement was evident after 2 weeks of treat-
ment,  as  the  patients  was  weaned  from  oxygen, 
and able to walk and swallow liquids, and at the 
end  of  the  treatment  an  excellent  radiological 
response  was  noted.  At  the  time  this  report  was 
written, the patient was receiving adjuvant chemo-
therapy. We had taken a written informed consent 
from  the  patient.  We  have  ethical  committee 
approval.
Discussion
EMP is a soft tissue plasma cell tumor occurring 
in the absence of systemic signs of multiple myelo-
ma, such as a bone osteolytic lesion, plasma cell 
infiltration in bone marrow, a lytic bone lesion, and 
serum or urine myeloma proteins [1]. A historical 
review [2] of 700 patients showed that there was 
head and neck involvement in 80%-90%, especially 
in the aerodigestive tract. Case reports of involve-
ment of the liver, pancreas, lungs, skin, and thyroid 
gland do exist. It is most unusual for this tumor to 
present  in  the  mediastinum  as  a  primary  solitary 
lesion. To date, only 12 cases of EMP involving the 
mediastinum have been reported in the English lan-
guage literature; mean age at presentation was 55 
years. Presentation (Table 1) included a mediasti-
num mass associated with intralobar effusion [3], 
pulmonary  nodules  [4],  multiple  myeloma  [5,6], 
and mimicking hemangioma [7]; however, the pre-
sented case is unusual, as it involved a solitary ante-
rior mediastinal mass that presented with grade 4 
dyspnea, and responded quickly during the course 
of treatment. The plasmacytoma in the presented 
case  was  aggressive,  which  was  evident  by 
increased  contrast  uptake  observed  with  PET,  in 
contrast to the lack of increased uptake in indolent 
plasmacytoma. The presented case also highlights 
the clinical usefulness of PET/CT in imaging plasma-
cytomas,  as  suggested  by  Masood  et  al.  [5]. 
Pathologically  proven  pleural  effusion  is  an  occa-
sional  finding  in  patients  with  multiple  myeloma, 
which occurs in approximately 6% of patients [8]. 
The cause of pleural effusion in the presented case 
was  not  clear  and  as  it  was  reactive,  lymphatic 
drainage  obstruction  caused  by  the  mediastinal 
mass might have been responsible. 
Plasma cell neoplasms are relatively sensitive to 
radiotherapy; however, a review of the literature by 
Alexiou et al. [2] reported that combined therapy 
(surgery and radiotherapy) results in better overall 
and recurrence-free survival (p=0.027). Nonetheless, 
these results span the greater part of a century (1905-
1997)  and  radiotherapy  techniques  have  changed 
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Table 1. Published reports of mediastinal mass
Serial no   Author  Presentation  Treatment  Follow-up
1  Divis and Sikl (1928)  Anterior mediastinum  Resection  Alive at 3 months
2  Bross (1931)  Posterior mediastinum  Resection  Necropsy report
3  Snapper (1953)  Mediastinum and lung with MM  Radiotherapy  Necropsy report
4  Niwa1 (1987)  Superior mediastinum  -  -
5  Miyazaki (1992)  Anterior mediastinum +lobar effusion  No treatment  Alive at 2 years
6  Moran (1995)  Anterior mediastinum  Chemotherapy  6 months
    Posterior mediastinum  Surgery  2 years (developed 
        multiple myeloma)
7  Ahmed (2000)  Posterior mediastinum  Surgery  Nor available 
8  Nandekar (2000)  Middle mediastinum mimics   Chemotherapy  Alive at 2 years
    hemangioma with MM 
9  Yamaguchi (2005)  Anterior mediastinum  Radiotherapy  Alive 
10  Lee (2005)  Posterior mediastinum  Radiotherapy  Alive at 6 months
11  Ashiq (2008)  Posterior mediastinum with MM  Chemotherapy   Not available
12  Hyemin (2010)  Anterior mediastinum + pleural nodules   Chemotherapy   Not available
    + pleural effusions with MM during that time. Currently, radiotherapy is the treat-
ment of choice for solitary plasmacytoma and the 
dose of 40-50 Gy (depending on tumor size) is deliv-
ered over 4-6 weeks. It is associated with a <5% risk 
of local recurrence and most carefully staged patients 
with solitary EMP can be cured [9, 10]. There is no 
published evidence for the role of adjuvant chemo-
therapy in the treatment of solitary extramedullary 
plasmacytoma Tsang et al. [11] and Holland et al. 
[12] suggest that tumours >5 cm are associated with 
a high risk of failure, which was a rationale for pro-
posing chemotherapy to the presented patient.
Though 5% of patients have coexistent multiple 
myeloma [11], our literature review suggests 30% 
involvement in mediastinal EMP . This indicates that 
plasmacytoma involving the mediastinum provides 
an  early  hint  to  the  diagnosis  of  occult  multiple 
myeloma and should be included in the differential 
diagnosis of mediastinal masses. Thusly, after the 
diagnosis  of  plasmacytoma,  aggressive  investiga-
tion for multiple myeloma is vital, as such patients 
can be candidates for adjuvant chemotherapy.
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